{"id":"https://openalex.org/W7213356000","doi":"https://doi.org/10.64898/2026.09.11.750978","title":"High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery","display_name":"High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery","publication_year":2026,"publication_date":"2026-09-14","ids":{"openalex":"https://openalex.org/W7213356000","doi":"https://doi.org/10.64898/2026.09.11.750978"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.11.750978","doi":"https://doi.org/10.64898/2026.09.11.750978","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.11.750978","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/14/2026.09.11.750978.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/14/2026.09.11.750978.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029505550","display_name":"Matteo Martufi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matteo Martufi","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159756656","display_name":"Eleni Karagianni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eleni Karagianni","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009060536","display_name":"Tasos Papanikos","orcid":"https://orcid.org/0000-0001-8971-6221","observed_orcids":["https://orcid.org/0000-0001-8971-6221"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tasos Papanikos","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111618563","display_name":"Tim G. Ashlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tim Ashlin","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015856088","display_name":"Aikaterini Geladaki","orcid":"https://orcid.org/0000-0002-0530-4252","observed_orcids":["https://orcid.org/0000-0002-0530-4252"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aikaterini Geladaki","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071982367","display_name":"Benedetta Carbone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Benedetta Carbone","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080046329","display_name":"Katja S. Remlinger","orcid":"https://orcid.org/0009-0001-5372-0920","observed_orcids":["https://orcid.org/0009-0001-5372-0920"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katja Remlinger","raw_affiliation_strings":["GlaxoSmithKline R&D, 1250S Collegeville Rd, Collegeville, PA, 19426 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, 1250S Collegeville Rd, Collegeville, PA, 19426 USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151875119","display_name":"Andres Quintero Moreno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andres Quintero Moreno","raw_affiliation_strings":["GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038492155","display_name":"William G. Pembroke","orcid":"https://orcid.org/0000-0002-5863-4255","observed_orcids":["https://orcid.org/0000-0002-5863-4255"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"William Pembroke","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122380684","display_name":"Charlie Haslam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlie Haslam","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062464369","display_name":"Nico Zinn","orcid":"https://orcid.org/0000-0003-3592-5751","observed_orcids":["https://orcid.org/0000-0003-3592-5751"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nico Zinn","raw_affiliation_strings":["GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079139279","display_name":"Denise F. Vlachou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Denise Vlachou","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151875518","display_name":"Margarida Almeida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Margarida Almeida","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151864099","display_name":"Dimitrios Tsaousis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dimitrios Tsaousis","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108990617","display_name":"Stephan Gade","orcid":"https://orcid.org/0009-0001-9953-3397","observed_orcids":["https://orcid.org/0009-0001-9953-3397"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Gade","raw_affiliation_strings":["GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151724712","display_name":"Bin Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bin Sun","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089371841","display_name":"Muhammad Ahmad Maqbool","orcid":"https://orcid.org/0000-0001-6757-0866","observed_orcids":["https://orcid.org/0000-0001-6757-0866"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Muhammad Maqbool","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108654323","display_name":"Holger Franken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Holger Franken","raw_affiliation_strings":["GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080584427","display_name":"Frederik Ziebell","orcid":"https://orcid.org/0000-0003-3673-1721","observed_orcids":["https://orcid.org/0000-0003-3673-1721"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frederik Ziebell","raw_affiliation_strings":["GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005420035","display_name":"Alessandro Di Tullio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alessandro Di Tullio","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125193979","display_name":"Lewis Entwistle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lewis Entwistle","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048060049","display_name":"Naren Srinivasan","orcid":"https://orcid.org/0000-0001-8424-7788","observed_orcids":["https://orcid.org/0000-0001-8424-7788"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Naren Srinivasan","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054154878","display_name":"Mercedes Lobera","orcid":"https://orcid.org/0000-0003-0803-1285","observed_orcids":["https://orcid.org/0000-0003-0803-1285"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mercedes Lobera","raw_affiliation_strings":["GlaxoSmithKline R&D, 200 Cambridge Park Drive, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, 200 Cambridge Park Drive, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082281666","display_name":"Lisa Mohamet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Lisa Mohamet","raw_affiliation_strings":["GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Gunnels Wood Rd, Hertfordshire, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082281666"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.28690001368522644,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11685","display_name":"Zebrafish Biomedical Research Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-throughput-drug-discovery","display_name":"high-throughput drug discovery","score":0.6639999747276306},{"id":"https://openalex.org/keywords/autoinflammatory-disease","display_name":"autoinflammatory disease","score":0.7020000219345093},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/drug-attrition","display_name":"drug attrition","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.741599977016449},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6607000231742859},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6541000008583069},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.6061999797821045},{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.5526000261306763},{"id":"https://openalex.org/C207177822","wikidata":"https://www.wikidata.org/wiki/Q5050812","display_name":"Genetic screen","level":4,"score":0.499099999666214},{"id":"https://openalex.org/C144501496","wikidata":"https://www.wikidata.org/wiki/Q5533489","display_name":"Genome editing","level":4,"score":0.4478999972343445},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4431999921798706},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41850000619888306},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.38179999589920044},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.367000013589859},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3659999966621399},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3625999987125397},{"id":"https://openalex.org/C2988867146","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Human disease","level":3,"score":0.3449999988079071},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.3402000069618225},{"id":"https://openalex.org/C19843653","wikidata":"https://www.wikidata.org/wiki/Q213907","display_name":"Model organism","level":3,"score":0.33660000562667847},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3337000012397766},{"id":"https://openalex.org/C6555983","wikidata":"https://www.wikidata.org/wiki/Q7181398","display_name":"Phenotypic screening","level":4,"score":0.3264000117778778},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.3212999999523163},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.3190999925136566},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3188000023365021},{"id":"https://openalex.org/C189014844","wikidata":"https://www.wikidata.org/wiki/Q189118","display_name":"Cell type","level":3,"score":0.31520000100135803},{"id":"https://openalex.org/C152662350","wikidata":"https://www.wikidata.org/wiki/Q815297","display_name":"Systems biology","level":2,"score":0.31470000743865967},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.3075999915599823},{"id":"https://openalex.org/C132455925","wikidata":"https://www.wikidata.org/wiki/Q16965677","display_name":"Cas9","level":4,"score":0.3066999912261963},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3019999861717224},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.2948000133037567},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2671000063419342},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2635999917984009},{"id":"https://openalex.org/C165864922","wikidata":"https://www.wikidata.org/wiki/Q411391","display_name":"Regulation of gene expression","level":3,"score":0.26179999113082886},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.25780001282691956},{"id":"https://openalex.org/C2910924664","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Human Induced Pluripotent Stem Cells","level":5,"score":0.2554999887943268},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.25290000438690186},{"id":"https://openalex.org/C47042493","wikidata":"https://www.wikidata.org/wiki/Q265799","display_name":"Human genetics","level":3,"score":0.2526000142097473}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.11.750978","doi":"https://doi.org/10.64898/2026.09.11.750978","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.11.750978","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/14/2026.09.11.750978.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.11.750978","doi":"https://doi.org/10.64898/2026.09.11.750978","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.11.750978","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/14/2026.09.11.750978.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213356000.pdf","grobid_xml":"https://content.openalex.org/works/W7213356000.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3039988661","https://openalex.org/W4393983695","https://openalex.org/W3153767862","https://openalex.org/W4392267053","https://openalex.org/W4402920320","https://openalex.org/W3132447645","https://openalex.org/W7051825716","https://openalex.org/W4300423312","https://openalex.org/W4414074153","https://openalex.org/W4224251731"],"abstract_inverted_index":{"Abstract":[0],"Human":[1],"induced":[2],"Pluripotent":[3],"Stem":[4],"Cell":[5],"(hiPSC)":[6],"models":[7],"have":[8,69,87],"revolutionised":[9],"drug":[10,27],"discovery,":[11],"offering":[12],"high":[13],"translational":[14],"relevance":[15],"for":[16,32,100,151],"recapitulating":[17],"disease":[18,161],"biology":[19],"and":[20,36,49,66,74,112,127,134,138],"thereby":[21],"the":[22,152],"potential":[23],"to":[24,60,124,159],"help":[25],"reduce":[26],"attrition.":[28],"Macrophages":[29],"are":[30],"pivotal":[31],"maintaining":[33],"tissue":[34],"homeostasis":[35],"orchestrating":[37],"immune":[38],"responses;":[39],"their":[40],"dysregulation":[41],"underpins":[42],"several":[43],"diseases,":[44],"including":[45],"autoinflammatory":[46],"disorders,":[47],"neurodegeneration,":[48],"cancer.":[50],"Therapeutically":[51],"targeting":[52],"this":[53,116,144],"cell":[54,145],"type":[55],"presents":[56],"an":[57],"attractive":[58],"strategy":[59],"simultaneously":[61],"influence":[62],"multiple":[63],"cellular":[64],"mediators":[65],"functions.":[67],"We":[68,86],"established":[70],"a":[71,169],"scalable,":[72],"semi-automated,":[73],"physiologically":[75],"relevant":[76],"hiPSC-derived":[77,91,125],"macrophage":[78,92],"model,":[79],"rigorously":[80],"characterised":[81],"through":[82],"deep":[83],"comparative":[84],"multi-omics.":[85],"also":[88],"integrated":[89,148],"our":[90],"platform":[93],"with":[94],"large-scale":[95],"CRISPR":[96],"screening":[97,122],"workflows":[98],"designed":[99],"parallel":[101],"genetic":[102,121,130,156],"interrogation":[103],"of":[104,106,154,172],"thousands":[105],"gene":[107],"targets,":[108],"in":[109,143],"both":[110],"arrayed":[111],"pooled":[113],"formats.":[114],"In":[115],"manuscript,":[117],"we":[118],"apply":[119],"those":[120],"methods":[123],"macrophages":[126],"showcase":[128],"how":[129],"perturbations":[131],"alter":[132],"pro-":[133],"anti-inflammatory":[135],"transcriptional":[136],"signatures":[137],"significantly":[139],"impact":[140],"functional":[141],"phenotypes":[142],"model.":[146],"This":[147],"approach":[149],"allows":[150],"exploration":[153],"novel":[155],"insights":[157],"linked":[158],"causal":[160],"biology,":[162],"advancing":[163],"myeloid":[164],"cell-associated":[165],"target":[166],"discovery":[167],"across":[168],"broad":[170],"spectrum":[171],"therapeutic":[173],"areas.":[174]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-16T00:00:00"}